 |
 |
|
|
RESÚMENES MAYO 2007 |
Mood - Anxiety
Disorders & Antidepressants – Mood Stabilizers
(Haga un click en la información del journal para acceder al resúmen)
Rash from Antiepileptic Drugs: Influence by
Gender, Age, and Learning Disability
Alvestad S, Lydersen S, Brodtkorb E
Epilepsia. 2007 May 1; [Epub ahead of
print]
Duloxetine treatment for role functioning improvement
in generalized anxiety disorder: three independent studies
Endicott
J, Russell JM, Raskin J, Detke MJ, Erickson J, Ball SG,
Marciniak M, Swindle RW
J Clin
Psychiatry. 2007 Apr;68(4):518-24
An evaluation of the cardiovascular safety
profile of duloxetine: findings from 42
placebo-controlled studies
Wernicke J, Lledo A, Raskin J, Kajdasz DK, Wang F
Lifetime and 12-Month Prevalence of Bipolar
Spectrum Disorder in the National Comorbidity Survey
Replication
Kathleen R. Merikangas,
Hagop S. Akiskal, Jules
Angst, Paul E. Greenberg, Robert M. A. Hirschfeld,
Maria Petukhova, Ronald C. Kessler
Arch Gen Psychiatry. 2007;64:543-552
Venlafaxine hyponatraemia:
incidence, mechanism and management
Roxanas M, Hibbert E, Field M
Aust N Z J Psychiatry. 2007 May;41(5):411-8
Duloxetine
increases stage 3 sleep and suppresses rapid eye movement (REM) sleep in
patients with major depression
Michael Kluge,
European Neuropsychopharmacology. Volume 17, Issue 8, July
2007, Pages 527-531
Cognitive Therapy Versus Medication in Augmentation and Switch Strategies as
Second-Step Treatments: A STAR*D Report
Michael
E. Thase, Edward S. Friedman, Melanie M. Biggs,
Stephen R. Wisniewski, Madhukar H. Trivedi, James F. Luther, Maurizio Fava,
Andrew A. Nierenberg, Patrick J. McGrath, Diane Warden, George Niederehe, Steven D. Hollon, and
A. John Rush
Am J
Psychiatry 164:739-752, May 2007
Acceptability of Second-Step
Treatments to Depressed Outpatients: A STAR*D Report
Stephen
R. Wisniewski, Maurizio Fava, Madhukar
H. Trivedi, Michael E. Thase,
Diane Warden, George Niederehe, Edward S. Friedman,
Melanie M. Biggs, Harold A. Sackeim, Kathy
Shores-Wilson, Patrick J. McGrath, Philip W. Lavori, Sachiko Miyahara and A. John Rush
Am J
Psychiatry 164:753-760, May 2007
Duloxetine treatment of dysthymia
and double depression: an open-label trial
Koran
LM, Aboujaoude EN, Gamel NN
J Clin
Psychiatry. 2007 May;68(5):761-5
Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in
a Department of Veterans Affairs setting
Friedman
MJ, Marmar CR, Baker DG, Sikes CR, Farfel GM
J Clin
Psychiatry. 2007 May;68(5):711-20
Once-daily
duloxetine 60 mg in the treatment of major
depressive disorder: Multicenter, double-blind,
randomized, paroxetine-controlled, non-inferiority
trial in China, Korea, Taiwan and Brazil
PHIL LEE, LIANG SHU, XIUFENG XU, CHUAN YUE WANG, MIN SOO LEE, CHIA-YIH LIU,
JIN PYO HONG, SANDRA RUSCHEL, JOEL RASKIN, SAMUEL A COLMAN, GAVAN A HARRISON
Psychiatry and Clinical Neurosciences 2007; 61 (3),
295–307
Different
serum concentrations of steady-state valproic acid in
two sustained-release formulations
NORIO YASUI-FURUKORI, MANABU SAITO, TAKU NAKAGAMI, TAKENORI NIIOKA, YASUSHI
SATO, AKIRA FUJII, SUNAO KANEKO
Psychiatry and Clinical Neurosciences 2007; 61 (3),
308–312
Selective
Serotonin Reuptake Inhibitors and Risk of Acute Pancreatitis:
A Population-Based Case-Control Study
Norgaard, Mette; Jacobsen, Jacob;
Gasse, Christiane;
Pedersen, Lars; Mortensen, Preben Bo; Sorensen, Henrik Toft
Journal of Clinical
Psychopharmacology. 27(3):259-262,
June 2007
The Role of
Anticonvulsant Drugs in Anxiety Disorders: A Critical Review of the Evidence
Mula,
Marco; Pini, Stefano; Cassano, Giovanni B
Journal of Clinical
Psychopharmacology. 27(3):263-272,
June 2007
Depressive Symptoms in
Subjects With Diagnosed and Undiagnosed Type 2
Diabetes
Mirjam
J. Knol, Eibert R. Heerdink, Antoine C. G. Egberts, Mirjam I. Geerlings, Kees J. Gorter, Mattijs E. Numans, Diederick E. Grobbee, Olaf H. Klungel, and Huibert Burger
Psychosomatic Medicine 69:300-305 (2007)
Anxiety, Depression, and
Cause-Specific Mortality: The HUNT Study
Arnstein
Mykletun, Ottar Bjerkeset, Michael Dewey, Martin Prince, Simon Overland, nd Robert Stewart
Psychosomatic Medicine 69:323-331 (2007)
Efficacy of repetitive transcranial magnetic stimulation (rTMS)
in major depression : a review
J. Brunelin,
E. Poulet, C. Boeuve,
H. Zeroug-vial, T. d’Amato,
M. Saoud
L’Encephale. Vol 33 - N° 2 - Avril 2007:
p. 126 - 134
Escitalopram
and citalopram : the unexpected role of the R-enantiomer
C. Jacquot,
D.J. David, A.M. Gardier, C. Sánchez
L’Encephale. Vol 33 - N° 2 - Avril 2007 : p. 179 - 187
A double blind,
randomized, placebo-controlled trial of quetiapine as
an add-on therapy to lithium or divalproex for the
treatment of bipolar mania
Yatham, Lakshmi N; Vieta, Eduard; Young, Allan H; Moller, Hans-Jurgen; Paulsson, Bjorn; Vagero, Marten
International Clinical
Psychopharmacology. 22(4):212-220,
July 2007
Relative
antidepressant efficacy of bupropion and the
selective serotonin reuptake inhibitors in major depressive disorder:
gender-age interactions
Papakostas, George I; Kornstein,
Susan G; Clayton, Anita H; Soares, Claudio N; Hallett, Lindsay A; Krishen, Alok; Tucker, Vivian L
International Clinical Psychopharmacology.
22(4):226-229, July 2007
Interferon-induced Depression in Hepatitis
C: An Update
Brian Keefe
Current Psychiatry Reports
2007, 9:255-261
Augmentation Strategies for
Therapy Resistant Depression - A Review
Max Schmauß, Thomas Messer
Psychiat Prax 2007; 34: 165-174
Effectiveness of
antidepressants in the treatment of major depressive disorder in Latin America
Héctor J. Dueñas; Trisha
Dwight; Margaret E. McBride; Alan J.M. Brnabic;
Luis A. Semper; Dagmar
Holmgren; Angela M.A. Miranda-Scippa; Hernán G. Rincón; Héctor Aguilera;
Adrian Vargas
International
Journal of Psychiatry in Clinical Practice, Volume 11, Issue 2 2007 , pages 129 - 139
Anxiety and OC spectrum
disorders over life cycle
Eric Hollander
New treatment options for OCD
Naomi A. Fineberg
Modafinil
Augmentation for Residual Symptoms of Fatigue in Patients with a Partial
Response to Antidepressants
Jenny
Y Lam, Maisha Kelly Freeman, Marshall E Cates
The
Annals of Pharmacotherapy: Vol. 41, No. 6, pp. 1005-1012
Caffeine and 35% carbon dioxide challenge
tests in panic disorder
Antonio E. Nardi,
Alexandre M. Valença, Fabiana L. Lopes, Valfrido L. de-Melo-Neto, Rafael C.
Freire, Andre B. Veras, Isabella Nascimento, Anna Lucia King, Gastão L.
Soares-Filho, Marco A. Mezzasalma, Walter A. Zin
Human Psychopharmacology: Clinical and Experimental. Volume
22, Issue 4, Pages 231 - 240
Tiagabine for social anxiety disorder
Boadie W. Dunlop, Laszlo Papp, Steven J. Garlow, Paul S. Weiss, Bettina T. Knight, Philip T. Ninan
Human Psychopharmacology: Clinical and Experimental. Volume
22, Issue 4, Pages 241 - 244
Hand-motor dysfunction in depression:
characteristics and pharmacological effects
Mergl R, Pogarell O, Juckel G, Rihl J, Henkel V, Frodl T, Muller-Siecheneder F, Karner M, Tigges P, Schroter A, Hegerl U
Clin EEG Neurosci. 2007 Apr;38(2):82-8
The role of life events in
social phobia
Ina Marteinsdottir; Anna Svensson; Marcus
Svedberg; Ulla Maria Anderberg;
Lars von Knorring
Nordic Journal of
Psychiatry, Volume 61, Issue 3 2007 , pages 207 - 212
A survey of five antidepressant properties
influencing clinician's treatment choices in MDD
|
|
|
| | | |
|
Neuropsychiatric Disease and Treatment. Volume: 3 | Issue: 1: 169-172
Treatment Adherence With Lithium and Anticonvulsant Medications Among Patients
With Bipolar Disorder
Martha Sajatovic, Marcia
Valenstein, Frederick Blow, Dara Ganoczy, and Rosalinda Ignacio
Psychiatr
Serv 58:855-863, June 2007
OCSDs
in the Forthcoming DSM-V
Eric Hollander, Suah
Kim, and Joseph Zohar
CNS Spectr.
2007;12(5):320-323
TEXTO GRATUITO
Obsessive-Compulsive Disorder: Boundary Issues
Naomi A. Fineberg, Sanjaya Saxena, Joseph Zohar, and Kevin J. Craig
CNS Spectr.
2007;12(5):359-364,367-375
TEXTO GRATUITO
The Relationship of Body Dysmorphic Disorder and Eating Disorders to
Obsessive-Compulsive Disorder
Katharine A.
Phillips and Walter H. Kaye
CNS Spectr.
2007;12(5):347-358
TEXTO GRATUITO
Obsessive-Compulsive Spectrum
Disorders: Cross-national and Ethnic Issues
Hisato Matsunaga and Soraya Seedat
CNS Spectr.
2007;12(5):392-400
TEXTO GRATUITO
Symptom Dimensions in
Obsessive-Compulsive Disorder: Implications for the DSM-V
James F. Leckman, Scott L. Rauch, and David Mataix-Cols
CNS Spectr.
2007;12(5):376-387,400
TEXTO GRATUITO
Antidepressant Drug-Drug
Interactions: Clinical Relevance and Risk Management
Charles B. Nemeroff, Sheldon H. Preskorn, C.
Lindsay DeVane
CNS Spectr.
2007;12(5 Suppl 7):1-16
TEXTO GRATUITO
suicide
attempts in bipolar disorder
GAZALLE, Fernando Kratz, HALLAL, Pedro Curi, TRAMONTINA, Juliana et al. Polypharmacy and Rev. Bras. Psiquiatr., Mar. 2007, vol.29, no.1, p.35-38
Ömer Aydemir, Artuner Deveci, Oryal E. Taskin, Fatma Taneli
and Aysen Esen-Danaci
Atypical antipsychotics
as “mood stabilizers”: A retrospective chart review